Find latest Myeloma videos · 500+ videos
UNC Lineberger Comprehensive Cancer Center
S

Updates on the Management of 1L Multiple Myeloma

By UNC Lineberger Comprehensive Cancer Center FEATURING Samuel Rubinstein
By UNC Lineberger Comprehensive Cancer Center FEATURING Samuel Rubinstein
82 views
September 16, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Related Videos

Penn Medicine Abramson Cancer Center

2025 Breast Cancer Highlights from International Medical Meetings: 5…

Thu, Mar 6, 2025
Total Health

2025 West Oncology Conference

Sat, Feb 8, 2025
21:06

New

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

394 views
15:00

FDA Approval of Isatuximab in 1L MM: Perspectives for Practice

Dana-Farber Cancer Institute

P. Richardson

710 views
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.0K views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

607 views
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

234 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

502 views
09:15

New

ASH 2024 Summary: Transplant in Myeloma - Key Factors in Decision-Ma…

2024 ASH Annual Meeting Insights Hub

A. Perrot

134 views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

688 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

633 views
09:07

CARTITUDE-4 Update: OS With Cilta-Cel vs. SOC in Len-Refractory Mult…

Maria-Victoria Mateos

229 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

337 views
21:41

Multiple Myeloma: Hot Topics in 2024

Yale Cancer Center

S. Browning

202 views
20:23

When to Consider Bispecific and CAR-T Therapy in MM

SOHO Brazil 2024

N. S. Raje

425 views
13:32

ASH 2024 Insights: Analyses of MRD Negativity Dynamics in the Phase …

2024 ASH Annual Meeting Insights Hub

R. Orlowski

106 views
04:55

New

ASH 2024 Insights: Dara vs. Len Maintenance in NDMM - Interim Result…

2024 ASH Annual Meeting Insights Hub

U. Shah

82 views
22:33

Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy

Integrity CE

S. Usmani, J. Hillengass

235 views
10:57

Indefinite Treatment of Multiple Myeloma: Strategies for Frail Patie…

Shaji Kumar

105 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

834 views
12:37

Evaluating Infection Risk in CAR T-Cell Therapy and Bispecific Antib…

Meera Mohan

144 views
AUTOPLAY